VICTORIA ARLAUSKAS: Open Payments
NPI 1861444218 · SPARTANBURG, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,612 in 91 payments from 24 companies in 2025. Trend: 2023 $1,599 · 2024 $1,400 · 2025 $1,612
Food & beverage: $1,612
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 16 | $238 |
| PFIZER INC. | 11 | $193 |
| Novartis Pharmaceuticals Corporation | 7 | $150 |
| Novo Nordisk Inc | 9 | $139 |
| Bayer Healthcare Pharmaceuticals Inc. | 8 | $129 |
| Sumitomo Pharma America, Inc. | 5 | $108 |
| Amgen Inc. | 5 | $83 |
| Daiichi Sankyo Inc. | 3 | $81 |
| GlaxoSmithKline, LLC. | 4 | $68 |
| Abbott Laboratories | 2 | $49 |
Products named: LEQVIO, Kerendia, UBRELVY, GEMTESA, INJECTAFER, PREVNAR 20, TRELEGY ELLIPTA, NURTEC ODT.
Industry payments across SC — which companies pay providers there.
